154 related articles for article (PubMed ID: 34134932)
1. Heterogeneous Manifestations of Posttransplant Lymphoma in Renal Transplant Recipients: A Case Series.
Patil R; Prashar R; Patel A
Transplant Proc; 2021 Jun; 53(5):1519-1527. PubMed ID: 34134932
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.
Ellis D; Jaffe R; Green M; Janosky JJ; Lombardozzi-Lane S; Shapiro R; Scantlebury V; Vivas C; Jordan ML
Transplantation; 1999 Oct; 68(7):997-1003. PubMed ID: 10532541
[TBL] [Abstract][Full Text] [Related]
3. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
Srivastava T; Zwick DL; Rothberg PG; Warady BA
Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
[TBL] [Abstract][Full Text] [Related]
4. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.
Ferguson NN; Thomas CP; Hohl RJ; Syrbu SI; Stone MS; Wanat KA
Am J Dermatopathol; 2015 Oct; 37(10):790-4. PubMed ID: 25747810
[TBL] [Abstract][Full Text] [Related]
5. Rational management of posttransplant lymphoproliferative disorder in pediatric recipients.
Praghakaran K; Wise B; Chen A; Schwarz K; Colombani P
J Pediatr Surg; 1999 Jan; 34(1):112-5; discussion 115-6. PubMed ID: 10022154
[TBL] [Abstract][Full Text] [Related]
6. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
Transplantation; 2012 Jan; 93(1):73-81. PubMed ID: 22129761
[TBL] [Abstract][Full Text] [Related]
7. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
[TBL] [Abstract][Full Text] [Related]
8. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
9. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
Newell KA; Alonso EM; Whitington PF; Bruce DS; Millis JM; Piper JB; Woodle ES; Kelly SM; Koeppen H; Hart J; Rubin CM; Thistlethwaite JR
Transplantation; 1996 Aug; 62(3):370-5. PubMed ID: 8779685
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated Hodgkin's disease following renal transplantation.
Choi JH; Ahn MJ; Oh YH; Han SW; Kim HJ; Lee YY; Kim IS
Korean J Intern Med; 2006 Mar; 21(1):46-9. PubMed ID: 16646565
[TBL] [Abstract][Full Text] [Related]
11. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
12. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients.
Morton M; Coupes B; Roberts SA; Klapper PE; Byers RJ; Vallely PJ; Ryan K; Picton ML
Transplantation; 2013 Feb; 95(3):470-8. PubMed ID: 23222821
[TBL] [Abstract][Full Text] [Related]
14. Posttransplant lymphoproliferative disorders in kidney transplant recipients: an Iranian multicenter experience.
Einollahi B; Lessan-Pezeshki M; Nourbala MH; Simforoosh N; Pourfarziani V; Nemati E; Nafar M; Basiri A; Pour-Reza-Gholi F; Firoozan A; Ghadiani MH; Makhdoomi K; Ghafari A; Ahmadpour P; Oliaei F; Ardalan MR; Makhlough A; Samimagham HR; Azmandian J; Razeghi E; Shahbazian H
Iran J Kidney Dis; 2008 Oct; 2(4):227-33. PubMed ID: 19377242
[TBL] [Abstract][Full Text] [Related]
15. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
Guthery SL; Heubi JE; Bucuvalas JC; Gross TG; Ryckman FC; Alonso MH; Balistreri WF; Hornung RW
Transplantation; 2003 Apr; 75(7):987-93. PubMed ID: 12698085
[TBL] [Abstract][Full Text] [Related]
16. Posttransplant lymphoproliferative disease: treatment and outcome in renal transplant recipients.
Soler MJ; Puig JM; Mir M; Parrilla J; Pedro C; Salar A; Serrano S; Lloveras J
Transplant Proc; 2003 Aug; 35(5):1709-13. PubMed ID: 12962767
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of monomorphic post-transplant lymphoproliferative disorders.
Choi JH; Park BB; Suh C; Won JH; Lee WS; Shin HJ
J Korean Med Sci; 2010 Apr; 25(4):523-6. PubMed ID: 20357991
[TBL] [Abstract][Full Text] [Related]
18. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
[TBL] [Abstract][Full Text] [Related]
19. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of Epstein-Barr virus infection as a risk factor for post-transplant lymphoproliferative disorder in pediatric renal transplant recipients.
Köpf S; Tönshoff B
Pediatr Nephrol; 2004 Apr; 19(4):365-8. PubMed ID: 14963763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]